© 2005 Oxford University Press
ARTICLE |
Increased Lung Metastasis in Transgenic NM23-Null/SV40 Mice with Hepatocellular Carcinoma
Affiliations of authors: Unité Institut National de la Santé et de la Recherche Médicale 680, Faculté de Médecine Saint-Antoine, Université Pierre et Marie Curie, Paris, France (MB, AM, M-LL); Laboratoire d'Anatomie Pathologique, Hôpital Saint-Antoine, AP-HP, Paris, France (DW); Laboratoire de Biologie de la Différenciation et du Développement, Université de Bordeaux-2, Bordeaux, France (SA-D, J-YD); IBGC-CNRS, Université de Bordeaux-2, Bordeaux, France (IL); Laboratoire de Biomathématiques, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France (MD)
Correspondence to: Marie-Lise Lacombe, PhD, INSERM U.680, Faculté de Médecine Saint-Antoine, 27 rue Chaligny, 75571 Paris cedex 12, France (e-mail: lacombe{at}st-antoine.inserm.fr).
Background: The metastasis-suppressing role of the NM23 gene in the metastatic spread of solid tumors is still debated. We examined the role of NM23 in tumor development and metastatic dissemination by using transgenic mice that lack mouse NM23 (NM23-M1) in two mouse models of hepatocellular carcinoma (HCC) that recapitulate all steps of tumor progression. Methods: We induced HCC in mice that contained (NM23-M1+/+) or lacked (NM23-M1–/–) NM23-M1 by diethylnitrosamine injection or by a crossing scheme that transferred a transgene that leads to liver expression of simian virus 40 large T antigen (ASV mice). We used microscopic examination and immunohistochemistry to analyze tumor progression. Expression of Nm23 protein isoforms (Nm23-M1 and Nm23-M2) and several tumor markers was analyzed in the primary tumor and in metastases by Western blotting. The statistical significance of differences in the incidence of Nm23-M2 overexpression in null mice relative to that in wild-type mice was tested by a one-sided Fisher's exact test. The statistical significance of differences in the incidence of metastases was examined using one-sided chi-square tests. All other statistical tests were two-sided. Results: In both models, Nm23-M1 and/or Nm23-M2 were overexpressed in the primary liver tumors compared with nontumor liver tissue; however, the lack of the NM23-M1 gene had no effect on primary tumor formation in either model. ASV mice developed pulmonary metastases that were positive for the Hep-Par 1 antibody, which recognizes a specific hepatocyte antigen, whereas the few pulmonary nodules that developed in diethylnitrosamine-injected mice were negative for this antigen. Statistically significantly more ASV/NM23-M1–/– mice than ASV/NM23-M1+/+ mice developed lung metastases (69.2% versus 37.5%; difference = 31.7%, 95% confidence interval = 13.1% to 50.3%; P<.001). In ASV/NM23-M1+/+ mice, immunohistochemical staining for Nm23-M1 was highly heterogeneous among the primary liver tumors, but weak or negative among lung metastases. Conclusions: The lack of NM23-M1 expression promotes metastasis in the SV40 animal model of liver carcinogenesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. S. Steeg, C. E. Horak, and K. D. Miller Clinical-Translational Approaches to the Nm23-H1 Metastasis Suppressor Clin. Cancer Res., August 15, 2008; 14(16): 5006 - 5012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Qu, J. Long, Q. Cai, X.-O. Shu, H. Cai, Y.-T. Gao, and W. Zheng Genetic Polymorphisms of Metastasis Suppressor Gene NME1 and Breast Cancer Survival Clin. Cancer Res., August 1, 2008; 14(15): 4787 - 4793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Nallamothu, J. A. Woolworth, V. Dammai, and T. Hsu awd, the Homolog of Metastasis Suppressor Gene Nm23, Regulates Drosophila Epithelial Cell Invasion Mol. Cell. Biol., March 15, 2008; 28(6): 1964 - 1973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-W. Chen, S. Paliwal, K. Draheim, S. R. Grossman, and B. C. Lewis p19Arf Inhibits the Invasion of Hepatocellular Carcinoma Cells by Binding to C-terminal Binding Protein Cancer Res., January 15, 2008; 68(2): 476 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Horak, A. Mendoza, E. Vega-Valle, M. Albaugh, C. Graff-Cherry, W. G. McDermott, E. Hua, M. J. Merino, S. M. Steinberg, C. Khanna, et al. Nm23-H1 Suppresses Metastasis by Inhibiting Expression of the Lysophosphatidic Acid Receptor EDG2 Cancer Res., December 15, 2007; 67(24): 11751 - 11759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Horak, J. H. Lee, A. G. Elkahloun, M. Boissan, S. Dumont, T. K. Maga, S. Arnaud-Dabernat, D. Palmieri, W. G. Stetler-Stevenson, M.-L. Lacombe, et al. Nm23-H1 Suppresses Tumor Cell Motility by Down-regulating the Lysophosphatidic Acid Receptor EDG2 Cancer Res., August 1, 2007; 67(15): 7238 - 7246. [Abstract] [Full Text] [PDF]
|
|